Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $16.85 USD
Change Today -0.69 / -3.93%
Volume 921.7K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - halozyme therapeutics inc (HALO)

Name (Connections)Board RelationshipsTitleKey Developments
Kathryn Falberg 62 RelationshipsChairman of the Board, Chairman of Audit Committee and Member of Compensation Committee 
Kenneth Kelley MBA 30 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Matthew Posard 16 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - halozyme therapeutics inc (HALO)

Name (Connections)Board RelationshipsTitle
Kathryn Falberg 62 RelationshipsChairman of the Board, Chairman of Audit Committee and Member of Compensation Committee
Connie Matsui 58 RelationshipsIndependent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee
HALO Compensation vs. Industry
593.4K
354.1K
Chief Executive Officer
312.6K
262.5K
Chief Operating Officer
Share price activity for HALOZYME THERAPEUTICS INC (HALO)
52 Week Price Performance
HALO
Industry Average

Nominating Committee* - halozyme therapeutics inc (HALO)

Name (Connections)Board RelationshipsTitleKey Developments
Connie Matsui 58 RelationshipsIndependent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance CommitteeHalozyme Therapeutics, Inc. Announces Executive Changes
08/24/15
Kenneth Kelley MBA 30 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeHalozyme Therapeutics, Inc. Appoints Jeffrey W. Henderson to its Board of Directors
08/6/15
Matthew Posard 16 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeHalozyme Therapeutics Appoints Harry J. Leonhardt, Esq. as Senior Vice President, General Counsel and Chief Compliance Officer
04/13/15

Corporate Governance Committee* - halozyme therapeutics inc (HALO)

Name (Connections)Board RelationshipsTitle
Kenneth Kelley MBA 30 RelationshipsChairman of the Board, Chairman of Audit Committee and Member of Compensation Committee
Connie Matsui 58 RelationshipsIndependent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee
Matthew Posard 16 Relationships--
HALO and Competitor
Insiders vs. External
Board
6%
94%
Halozyme Therapeutics, Inc.
10%
90%
Valeant Pharmaceuticals International, Inc.
19%
81%
Amphastar Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - halozyme therapeutics inc (HALO)

Name (Board Relationships)/Title Board Affiliations
Sue Bailey 47 Relationships
Member of Scientific Advisory Board
No other board affiliations
William Basuk 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
Gerhard Baumgartner 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jeffrey Bleil 16 Relationships
Member of the Advisory Board
No other board affiliations
Thomas Edgington 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Gregory Frost 16 Relationships
Chairman of Scientific Advisory Board
No other board affiliations
Scott Greenbaum 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Von Hoff 578 Relationships
Member of the Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $16.85 USD -0.69

HALO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amphastar Pharmaceuticals Inc $13.22 USD -0.37
Valeant Pharmaceuticals International Inc C$301.25 CAD -6.75
View Industry Companies
 

Industry Analysis

HALO

Industry Average

Valuation HALO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 20.7x
Price/Book 44.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 19.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.